High Yield Handout: AKI Flashcards
Define AKI clinically
Serum creatinine > 0.3 within 48 hours or >50% within 7 days
or
urine output <0.5 mL/kg/hour for >6 hours
CardioRenal Syndrome
condition where therapy to relieve congestive symptoms of HF is limited by decline in renal function bidirectional
How do we calculate GFR
using creatinine a small frail, old person may have lower muscle mass therefore only experience a mild elevation of creatinine with renal insufficiency
KDIGO stage 1
increase in serum creatinine >0.3 or 50-99%
or
urine output of <0.5 for 6-12 hours
KDIGO stage 2
increase in serume creatinine of 100-199%
or
urine output of <0.5 for 12-24
KDIGO stage 3
increase in serum creatinine >200%
increase in serum creatinine of >0.3 to >4.0
urine output of <0.3 for >24 hours or anuria >12 hours
initiation of renal replacement therapy
What data is important in the AKI case we had
increase in BUN/Cr
BNP declining
improvement of chest x-ray
normal EF per echo
AKI symptoms
oliguria
dyspnea
worsening edema
tachycardia
hypotension
JVD
liver distension/tenderness
distended abdomen
anascara
Is severe generalized edema that extends from the lower extremity proximally. It can
cause ascites as well as subcutaneous edema; associated with heart failure, cirrhosis, severe
malnutrition and renal failure.
Fluid wave
detects large volumes of free intrabdominal fluid. It has a specificity of 80-90%; a positive finding rules in ascites. However, its sensitivity is ~50%, so a negative test does not exclude ascites (i.e. it is volume dependent).
PND
Describes episodes of sudden dyspnea and orthopnea that awaken patient from sleep prompting the patient to sit up and stand up. There may be associated wheezing and coughing. PND may be mimicked by nocturnal asthma attacks
puddle sign
~40-~50% sensitivity especially with small amount of ascites.
The patient places the ulnar surface of their
hand along the abdominal vertical midline. The
operator places one hand on one flank and taps
gently on the opposite flank. A positive sign
when the operator feels a moderate to strong
fluid wave emanating into the contralateral
side.
OSE for kidney
T10-T11
vagus nerve
Upper Ureter
T10-T11
Vagus
Lower Ureter
T12-L2
pelvic splanchnic nerve
Bladder
T12-L2
pelvic splanchnic nerve
Kidney Chapman points
Anterior: one inch lateral and one inch
superior to the umbilicus
Posterior: between the transverse process
of T12 and L1 (on the ipsilateral side)
5 model approach: Biomechanical
SD of OA/AA
SD of T-spin (T10-T11)
SD of psoas
5 model approach:
Respiratory/Circulatory
O2 via mask/nasal canula
Lymphatics
diaphragms
Thoracic Area (pec traction/doming the diaphragm/thoracic pump)
Abdominal Area (abdominal pump/sacral rocking/pelvic diaphragm)
Extremity (effleurage/petrissage/pedal pump)
Rib raising
5 model approach:
Neurologic
see other cards regarding nerve levels
5 model approach:
Metabolic/Energetic/Immune
Loop diuretics
Fluid restriction
Remove offending agents like NSAIDs, PPI
Adjust meds based on renal function
Monitor I/O’s, weights
5 model approach:
Behavioural
Exercise
Diet – restrict fluids
Avoid offending agents
Better management of CHF (inciting cause)
What are the possible mechanisms to account for AKI in conjunction with
AHF?
neurohumoral adaptations
reduced renal perfusion
increased renal venous pressure
associations with heart failure with preserved ejection fraction
neurohumoral adaptations and reduced renal perfusion
in the setting of HF, hemodynamic
derangements trigger activation of the sympathetic nervous system and
RAAS and increases in the release of vasopressin (andidiuretic hormone)
and endothelin-1, which promote salt and water retention and systemic
vasoconstriction. These pathways lead to disproportionate reabsorption
of urea compared with that of creatinine. They also overwhelm the
vasodilatory and natriuretic effects of natriuretic peptides, nitric oxide,
prostaglandins, and bradykinin. The systemic vasoconstriction increases
cardiac afterload which reduces cardiac output, can further reduce renal
perfusion.
increased renal venous pressure
Increases in intra-abdominal or central
venous pressure, which should increase renal venous pressure, reduces
GFR. In other words, there is an inverse relationship between central
venous pressure and GFR. However, the mechanism by which renal
venous pressure might lead to reduction in GFR is not well understood
Associations with heart failure with preserved ejection fraction (HFpEF):
renal dysfunction can lead to metabolic derangements resulting in
systemic inflammation and microvascular dysfunction, which can cause
cardiomyocyte stiffening, hypertrophy and interstitial fibrosis. Exact
relationships are not well understood.
how do we treat AKI
- Remove offending agents: NSAIDS, PPI, etc.
- Judicious use of loop diuretics (furosemide)
- Adjust medication dosing based on renal function
- Supportive care: oxygen
- Monitor weight, I’s & O’s
- Fluid restriction
- Monitor electrolytes (Na+, K+ ,Ca+, Mg+, etc.)
- Case management/manager
- Dietary consult
long term management for AKI
- Discussion with patient regarding personal wishes regarding Dialysis
(both short and long-term), as well as other end-of-life matters such as
Living Will and DPAHC. - Avoid nephrotoxic drugs, including OTC preparations such as NSAIDs,
PPI, etc. - Regular monitoring of electrolytes, patient weight, fluid status, etc.
complications of long term AKI management
- Progression to oligouria or anuria: Dialysis (Renal Replacement Therapy) may be ‘initiated
emergently when life-threatening changes in fluid, electrolyte, and acid-base balance exist,’ per
the KDIGO guidelines. RRT should be continued until renal function is recovered or because
continued provision of renal support is no longer consistent with the overall goals of care for
the patient.